Immediate Impact

1 by Nobel laureates 1 from Science/Nature 66 standout
Sub-graph 1 of 23

Citing Papers

Fibroblasts in cancer: Unity in heterogeneity
2023 Standout
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial
2022 Standout
1 intermediate paper

Works of Yoichiro Ogama being referenced

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects
2015
Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.
2002

Author Peers

Author Last Decade Papers Cites
Yoichiro Ogama 116 189 34 229 193 16 595
Harinder S. Garewal 100 139 25 276 180 14 607
Renée Baak-Pablo 112 176 15 100 187 16 669
G R Gray 66 59 47 241 82 26 529
Virginia Davenport 58 129 41 146 52 21 624
Fumiaki Nozawa 68 140 12 296 67 22 639
Masako Hiramatsu 163 201 15 174 69 25 595
Fi‐Tjen Mu 74 159 22 242 73 18 678
Hideki Tabara 39 122 7 292 109 21 600
Anthony Sferruzza 121 114 14 186 252 21 616
Jung Wook Park 28 63 28 144 83 22 584

All Works

Loading papers...

Rankless by CCL
2026